|Mr. Jeffrey G. McGonegal||CFO & Sec.||424.12k||N/A||66|
|Mr. John R. O'Rourke III||Chairman, CEO and Pres||N/A||N/A||31|
|Mr. Richard J. Whitcomb||Sr. VP of Corp. Devel.||N/A||N/A||56|
|Dr. Lyndal K. Hesterberg Ph.D.||Consultant||N/A||N/A||N/A|
Bioptix, Inc., through its subsidiary, BiOptix Diagnostics, Inc., develops enhanced surface plasmon resonance technology platform for the detection of molecular interactions. The company also focuses on animal healthcare and owns important intellectual property rights related to veterinary products. In addition, it has granted a license relating to single chain reproductive hormone technology for use in no-human mammals, which is under active development by the licensee bovine rFSH. The company was formerly known as Venaxis, Inc. and changed its name to Bioptix, Inc. in November 2016. Bioptix, Inc. was founded in 2000 and is based in Castle Rock, Colorado.
Riot Blockchain, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.